Umang Vohra Joins Hikma Board, Boosts Pharma Expertise

Umang Vohra has been appointed as Independent Non-Executive Director at Hikma Pharmaceuticals, effective December 1, 2026. He will also join the company’s Audit Committee and Nomination and Governance Committee. He currently serves as Chairman and Group CEO of Cohance Lifesciences. Previously, he served as Managing Director and Global CEO of Cipla, leading its global growth and transformation.

Earlier, he held senior leadership positions at Dr. Reddy's Laboratories, including Chief Financial Officer and Head of North America Generics and Corporate. He brings extensive experience across global pharmaceuticals, finance, business development and operations. His career also includes an earlier stint at PepsiCo, where he worked in financial planning. His appointment adds significant pharmaceutical industry and international business experience to Hikma’s Board.

#LeadershipUpdate #HikmaPharmaceuticals #UmangVohra #PharmaLeadership #cxolanes